Licensed Practical Nurse in Morris, IL Accepting Medicare
3 Licensed Practical Nurse nurses found. Showing 1 - 3
 Kendra M. Butz, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1401 Lakewood Dr, Suite A, Morris, IL 60450 Phone: 815-942-6323 Fax: 815-941-0308 |
Loretta Price, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1320 Union St, Morris, IL 60450 Phone: 815-941-3403 Fax: 815-941-2389 |
Jodi Lynn Valencia, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 114 E. Benton St., Morris, IL 60450 Phone: 815-513-5643 |
News Archive
Researchers discover how cells fine-tune oxygen use
Researchers at Johns Hopkins have discovered how cells fine-tune their oxygen use to make do with whatever amount is available at the moment.
Confidential Mediation Services opens new offices in San Francisco and Los Angeles
Confidential Mediation Services announces the opening of its offices in San Francisco and Los Angeles, facilitating the resolution of disputes arising within the medicinal marijuana industry. As the first and only firm in the United States specializing in conflict resolution for this industry, Confidential Mediation Services is poised to expand as marijuana enterprises enlarge, mature, and gain legitimacy.
XYNTHA approved for teatment of hemophilia A by FDA
Wyeth Pharmaceuticals, a division of Wyeth ( NYSE:WYE) , announced today that it has received approval from the U.S. Food and Drug Administration for XYNTHA(TM) (Antihemophilic Factor [Recombinant], Plasma/Albumin-Free), a recombinant factor VIII product, for patients with hemophilia A for both the control and prevention of bleeding episodes and surgical prophylaxis.
UCI study identifies transgenerational effects of tributyltin
Exposing pregnant mice to low doses of the chemical tributyltin - which is used in marine hull paint and PVC plastic - can lead to obesity for multiple generations without subsequent exposure, a UC Irvine study has found.
Early neutralizing response to SARS-CoV-2 dominated by IgA antibodies
Researchers from France and the U.S. demonstrated how severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection could induce an early and vigorous virus-specific IgA response that paves the way for the production of SARS-CoV-2 IgG antibodies, with even better neutralizing properties. Their paper is currently available on the medRxiv preprint server.
› Verified 1 days ago